Liver-specific deletion of Agpat5 had no effect on body weight, fat mass, hepatic steatosis, or plasma levels of LDL-cholesterol and HDL-cholesterol in any of the four dietary interventions. The gene discussed is AGPAT5; the disease is fatty liver disease.